WallStSmart
PCSA

Processa Pharmaceuticals Inc

NASDAQ: PCSA · HEALTHCARE · BIOTECHNOLOGY

$2.70
+1.89% today

Updated 2026-04-30

Market cap
$7.93M
P/E ratio
P/S ratio
1,320.06x
EPS (TTM)
$-10.36
Dividend yield
52W range
$2 – $20
Volume
0.1M

Processa Pharmaceuticals Inc (PCSA) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201020112012201320142015201620172018201920202021202220232024
Total assets$20000.00$5.31M$3.88M$2.94M$2.54M$104321.00$104321.00$2.98M$13.21M$10.88M$25.21M$26.46M$8.62M$5.79M$3.23M
Cash & equivalents$2.79M$1.03M$186864.00$21234.00$2090.00$2090.00$2.85M$1.74M$691536.00$15.42M$16.50M$6.50M$4.71M$1.19M
Current assets$2.80M$1.16M$514706.00$379209.00$104162.00$104162.00$2.95M$2.02M$1.01M$16.20M$18.33M$8.39M$5.63M$1.87M
Total liabilities$2.53M$1.32M$1.27M$1.33M$2.08M$2.08M$2.61M$3.51M$2.87M$2.27M$978405.00$1.15M$797484.00$1.53M
Current liabilities$330621.00$715652.00$1.12M$840053.00$2.08M$2.08M$2.60M$645704.00$1.19M$1.22M$971020.00$998556.00$730579.00$1.53M
Long-term debt$0.00$0.00$0.00$0.00$44885.00
Shareholder equity$20000.00$2.78M$2.56M$1.67M$1.21M$-85705.00$-1.98M$373164.00$9.70M$8.01M$22.94M$25.49M$7.47M$4.99M$1.70M
Retained earnings$-941097.00$-3.43M$-6.81M$-11.85M$-14.87M$-14.87M$-3.86M$-7.62M$-10.98M$-25.40M$-36.82M$-64.25M$-75.37M$-87.22M
Accounts receivable$9500.00$30451.00$19200.00$1310.00$62709.00$21583.00$231754.00$70274.00
Inventory$48749.00$228256.00$219203.00$0.00$0.00$0.00$0.00
Goodwill$0.00$0.00$0.00$0.00